Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reisman

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Archives of Dermatological Research|December 24, 2013
Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skinScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 17, 2018
The development of a reference database with the Topcon 3D OCT-1 MaestroMichael Chaglasian, Murray Fingeret, Pinakin Gunvant Davey, et al.
The American Journal of Medicine|October 1, 1980
Association of monocytic leukemia in patients with extreme leukocytosisJ Cuttner, M S Conjalka, M Reilly, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2012
Bardoxolone methyl decreases megalin and activates nrf2 in the kidneyScott A Reisman, Glenn M Chertow, Sudarshan Hebbar, et al.
Drug Design, Development and Therapy|May 24, 2019
Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primatesScott A Reisman, Sarabjit S Gahir, Chun-Yue I Lee, et al.
Redox Biology|December 24, 2013
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney diseaseMohammad A Aminzadeh, Scott A Reisman, Nosratola D Vaziri, et al.
Toxicology and Applied Pharmacology|July 12, 2008
Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicityYuji Tanaka, Lauren M Aleksunes, Michael J Goedken, et al.
Radiation Research|April 12, 2014
Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitisScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
Journal of Lower Genital Tract Disease|July 2, 2014
Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging studySteven E Chavoustie, Mark Jacobs, Howard A Reisman, et al.
Investigational New Drugs|January 1, 1985
Phase I-II trial of mitoxantrone in acute leukemia: an interim reportZ A Arlin, G Dukart, I Schoch, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Archives of Dermatological Research|December 24, 2013
Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skinScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 17, 2018
The development of a reference database with the Topcon 3D OCT-1 MaestroMichael Chaglasian, Murray Fingeret, Pinakin Gunvant Davey, et al.
The American Journal of Medicine|October 1, 1980
Association of monocytic leukemia in patients with extreme leukocytosisJ Cuttner, M S Conjalka, M Reilly, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2012
Bardoxolone methyl decreases megalin and activates nrf2 in the kidneyScott A Reisman, Glenn M Chertow, Sudarshan Hebbar, et al.
Drug Design, Development and Therapy|May 24, 2019
Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primatesScott A Reisman, Sarabjit S Gahir, Chun-Yue I Lee, et al.
Redox Biology|December 24, 2013
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney diseaseMohammad A Aminzadeh, Scott A Reisman, Nosratola D Vaziri, et al.
Toxicology and Applied Pharmacology|July 12, 2008
Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicityYuji Tanaka, Lauren M Aleksunes, Michael J Goedken, et al.
Radiation Research|April 12, 2014
Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitisScott A Reisman, Chun-Yue I Lee, Colin J Meyer, et al.
Journal of Lower Genital Tract Disease|July 2, 2014
Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging studySteven E Chavoustie, Mark Jacobs, Howard A Reisman, et al.
Investigational New Drugs|January 1, 1985
Phase I-II trial of mitoxantrone in acute leukemia: an interim reportZ A Arlin, G Dukart, I Schoch, et al.
Pageof 7